DiaGenic ASA Reports Completion of Data Collection and Genetic Analyses in a Unique Study on Familial Parkinson's Disease

Published: May 08, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: DiaGenic ASA (OSE:DIAG): DiaGenic today reports on the finalization of data collection and database lock of a blinded study in a Norwegian cohort of 80 patients with familial Parkinson’s disease (PD). The majority of these patients are carrying a mutation in the parkin 8 gene (also called LRRK2) that significantly increases the risk of developing PD. Patients recruited from St Olavs University Hospital under the lead of Principal Investigator Professor Jan Aasly are all LRRK2 mutation carriers with or without the disease or healthy relatives. Unblinding of the study is set to the May 16th and analysis and reporting is expected to be completed during summer 2012.

Back to news